A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of ABT-333.

Trial Profile

A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of ABT-333.

Completed
Phase of Trial: Phase I

Latest Information Update: 11 Oct 2010

At a glance

  • Drugs Dasabuvir; Ketoconazole
  • Indications Hepatitis C
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Abbott Laboratories
  • Most Recent Events

    • 26 Apr 2009 Pharmacokinetc results reported at the 44th Annual Meeting of the European Association for the Study of the Liver.
    • 04 Mar 2009 Actual patient number changed from 36 to 45 as reported by ClinicalTrials.gov.
    • 04 Mar 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top